Short-term and long-term stroke risk following SARS-CoV-2 infection in relation to disease severity: a Danish national cohort study

被引:0
|
作者
Skov, Camilla Schade [1 ,2 ]
Pottegard, Anton [3 ]
Andersen, Jacob Harbo [3 ]
Andersen, Grethe [4 ,5 ]
Lassen, Annmarie Touborg [1 ,2 ]
机构
[1] Odense Univ Hosp, Dept Emergency Med, Odense, Denmark
[2] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[3] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol Pharm & Environm Med, Odense, Denmark
[4] Aarhus Univ Hosp, Dept Neurol, Aarhus, Denmark
[5] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
来源
BMJ OPEN | 2024年 / 14卷 / 07期
关键词
SARS-CoV-2; Infection; Stroke; EPIDEMIOLOGY; Public health; ACUTE ISCHEMIC-STROKE; COVID-19; HOSPITALIZATION; MORTALITY; TRENDS;
D O I
10.1136/bmjopen-2023-083171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Studies have reported high incidences of stroke in patients hospitalised with SARS-CoV-2, but the impact of disease severity is unexplored. We aimed to estimate the risk of incident ischaemic stroke in SARS-CoV-2 test-positive individuals compared with test-negative individuals stratified by disease severity during acute infection and post infection.Design A register-based cohort study.Setting A Danish nationwide study.Participants All Danish adults who had PCR tests for SARS-CoV-2 performed between 1 March 2020 and 30 November 2021. Test-positive individuals were included at their first positive test. For individuals tested prior to 30 November 2021, we randomly sampled an index date from the distribution of test dates among SARS-CoV-2 test-positive individuals. Test-positive individuals were followed during the acute phase of infection (days 0-14) and post infection (180 days after the acute phase). Test-negative individuals were followed in equivalent time periods.Primary and secondary outcome measures Incident ischaemic stroke risk in SARS-CoV-2 test-positive individuals compared with test-negative individuals during acute infection and post infection. We calculated subdistribution HRs (SHR) with death as a competing risk using propensity score weighting as confounder control. The risk was stratified according to disease severity: community managed, hospitalised, or admission to the intensive care unit.Results Among 3 910 219 SARS-CoV-2 PRC-tested individuals, 356 421 test-positive and 3 067 456 test-negative individuals were included. A positive SARS-CoV-2 test was associated with an SHR of 3.32 (95% CI 2.60 to 4.25) overall for stroke compared with test negative in the acute phase. In the postinfection period, the risk of stroke remained increased in individuals hospitalised during the acute phase (SHR 1.85, 95% CI 1.45 to 2.37). Individuals with community-managed SARS-CoV-2 had no increased long-term risk of stroke (SHR 1.01, 95% CI 0.88 to 1.16).Conclusion SARS-CoV-2 infection is associated with increased stroke risk. Disease severity seems to be an important factor. Individuals with community-managed SARS-CoV-2 had no increased stroke risk.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Short- and Long-Term Self-Reported Audiovestibular Symptoms of SARS-CoV-2 Infection in Hospitalized and Nonhospitalized Patients
    Almishaal, Ali A. A.
    Alrushaidan, Ali A. A.
    AUDIOLOGY AND NEUROTOLOGY, 2022, 27 (04) : 297 - 311
  • [42] Long-term symptoms after SARS-CoV-2 infection in a cohort of hospital employees: duration and predictive factors
    Rosalie Gruber
    María Verónica Montilva Ludewig
    Christina Weßels
    Gerlinde Schlang
    Svenja Jedhoff
    Swetlana Herbrandt
    Frauke Mattner
    BMC Infectious Diseases, 24
  • [43] Short-Term Outcomes in Neonates and Preterm Infants with SARS-CoV-2 Infection Acquired Postpartum
    Karabay, Meltem
    Toptan, Hande
    JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2021, 16 (06) : 290 - 295
  • [44] Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection
    Montefusco, Laura
    Ben Nasr, Moufida
    D'Addio, Francesca
    Loretelli, Cristian
    Rossi, Antonio
    Pastore, Ida
    Daniele, Giuseppe
    Abdelsalam, Ahmed
    Maestroni, Anna
    Dell'Acqua, Marco
    Ippolito, Elio
    Assi, Emma
    Usuelli, Vera
    Seelam, Andy Joe
    Fiorina, Roberta Maria
    Chebat, Enrica
    Morpurgo, Paola
    Lunati, Maria Elena
    Bolla, Andrea Mario
    Finzi, Giovanna
    Abdi, Reza
    Bonventre, Joseph V.
    Rusconi, Stefano
    Riva, Agostino
    Corradi, Domenico
    Santus, Pierachille
    Nebuloni, Manuela
    Folli, Franco
    Zuccotti, Gian Vincenzo
    Galli, Massimo
    Fiorina, Paolo
    NATURE METABOLISM, 2021, 3 (06) : 774 - +
  • [45] Long-term efficacy and safety of SARS-CoV-2 vaccination in patients with chronic kidney disease, on dialysis or after kidney transplantation: a national prospective observational cohort study
    Bouwmans, P.
    Messchendorp, A. L.
    Sanders, J. S.
    Hilbrands, L.
    Reinders, M. E. J.
    Vart, P.
    Bemelman, F. J.
    Abrahams, A. C.
    van den Dorpel, M. A.
    Ten Dam, M. A.
    de Vries, A. P. J.
    Rispens, T.
    Steenhuis, M.
    Gansevoort, R. T.
    Hemmelder, M. H.
    BMC NEPHROLOGY, 2022, 23 (01)
  • [46] No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
    Laurenzi, Andrea
    Caretto, Amelia
    Molinari, Chiara
    Mercalli, Alessia
    Melzi, Raffaella
    Nano, Rita
    Tresoldi, Cristina
    Querini, Patrizia Rovere
    Ciceri, Fabio
    Lampasona, Vito
    Bosi, Emanuele
    Scavini, Marina
    Piemonti, Lorenzo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (03) : E1009 - E1019
  • [47] Long-term observation of antibody titers against SARS-CoV-2 following vaccination
    Sugiyama, Kazuo
    Suzuki, Chouji
    Aoyama, Masanori
    Toyota, Nobuhiko
    Nakagawa, Nozomi
    Shozu, Makio
    Nakai, Kanji
    Iwano, Keiji
    PUBLIC HEALTH IN PRACTICE, 2022, 4
  • [48] Outcomes following SARS-CoV-2 infection in individuals with and without inflammatory rheumatic diseases: a Danish nationwide cohort study
    Svensson, Annemarie Lyng Lyng
    Emborg, Hanne-Dorthe
    Bartels, Lars Erik
    Ellingsen, Torkell
    Adelsten, Thomas
    Cordtz, Rene
    Dreyer, Lene
    Obel, Niels
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (10) : 1359 - 1367
  • [49] Long-term neuropsychiatric sequelae of Delta versus Omicron SARS-CoV-2 infection
    Wee, Liang En
    Lim, Jue Tao
    Tay, An Ting
    Pang, Deanette
    Dickens, Borame
    Chiew, Calvin J.
    Ong, Benjamin
    Lye, David Chien Boon
    Tan, Kelvin Bryan
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (04) : 531 - 539
  • [50] Long-term sequelae of SARS-CoV-2 two years following infection: exploring the interplay of biological, psychological, and social factors
    Verveen, Anouk
    Nugroho, Fajar Agung
    Bucur, Ioan Gabriel
    Wynberg, Elke
    van Willigen, Hugo D. G.
    Davidovich, Udi
    Lok, Anja
    van Charante, Eric P. Moll
    de Bree, Godelieve J.
    de Jong, Menno D.
    Kootstra, Neeltje
    Claassen, Tom
    de Jonge, Marien I.
    Heskes, Tom
    Prins, Maria
    Knoop, Hans
    Nieuwkerk, Pythia T.
    PSYCHOLOGICAL MEDICINE, 2024,